{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:16:46Z","timestamp":1790691406495,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,2,27]],"date-time":"2014-02-27T00:00:00Z","timestamp":1393459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,2,27]],"date-time":"2014-02-27T00:00:00Z","timestamp":1393459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1038\/gt.2014.17","type":"journal-article","created":{"date-parts":[[2014,2,27]],"date-time":"2014-02-27T11:34:33Z","timestamp":1393500873000},"page":"427-433","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Long-term correction of biochemical and neurological abnormalities in MLD mice model by neonatal systemic injection of an AAV serotype 9 vector"],"prefix":"10.1038","volume":"21","author":[{"given":"N","family":"Miyake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Asakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,27]]},"reference":[{"key":"BFgt201417_CR1","volume-title":"Metachromatic Leukodystrophy. The Metabolic and Molecular Bases of Inherited Disease","author":"K von Figura","year":"2001","unstructured":"von Figura K, Gieselmann V, Jaeken J . Metachromatic Leukodystrophy. The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill: New York, 2001."},{"key":"BFgt201417_CR2","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1093\/hmg\/ddi126","volume":"14","author":"U Matzner","year":"2005","unstructured":"Matzner U, Herbst E, Hedayati KK, Lullmann-Rauch R, Wessig C, Schroder S et al. Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy. Hum Mol Genet 2005; 14: 1139\u20131152.","journal-title":"Hum Mol Genet"},{"key":"BFgt201417_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0304-4157(95)00004-B","volume":"1241","author":"A Hille-Rehfeld","year":"1995","unstructured":"Hille-Rehfeld A . Mannose 6-phosphate receptors in sorting and transport of lysosomal enzymes. Biochim Biophys Acta 1995; 1241: 177\u2013194.","journal-title":"Biochim Biophys Acta"},{"key":"BFgt201417_CR4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/iub.284","volume":"62","author":"M Beck","year":"2010","unstructured":"Beck M . Therapy for lysosomal storage disorders. IUBMB Life 2010; 62: 33\u201340.","journal-title":"IUBMB Life"},{"key":"BFgt201417_CR5","first-page":"2686","volume":"118","author":"KP Ponder","year":"2008","unstructured":"Ponder KP . Immune response hinders therapy for lysosomal storage diseases. J Clin Invest 2008; 118: 2686\u20132689.","journal-title":"J Clin Invest"},{"key":"BFgt201417_CR6","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3324\/haematol.2011.058644","volume":"97","author":"MA Saif","year":"2012","unstructured":"Saif MA, Bigger BW, Brookes KE, Mercer J, Tylee KL, Church HJ et al. Hematopoietic stem cell transplantation improves the high incidence of neutralizing allo-antibodies observed in Hurler's syndrome after pharmacological enzyme replacement therapy. Haematologica 2012; 97: 1320\u20131328.","journal-title":"Haematologica"},{"key":"BFgt201417_CR7","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1093\/hmg\/dds086","volume":"21","author":"F Matthes","year":"2012","unstructured":"Matthes F, Stroobants S, Gerlach D, Wohlenberg C, Wessig C, Fogh J et al. Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age. Hum Mol Genet 2012; 21: 2599\u20132609.","journal-title":"Hum Mol Genet"},{"key":"BFgt201417_CR8","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/mt.2008.305","volume":"17","author":"U Matzner","year":"2009","unstructured":"Matzner U, Lullmann-Rauch R, Stroobants S, Andersson C, Weigelt C, Eistrup C et al. Enzyme replacement improves ataxic gait and central nervous system histopathology in a mouse model of metachromatic leukodystrophy. Mol Ther 2009; 17: 600\u2013606.","journal-title":"Mol Ther"},{"key":"BFgt201417_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/sj.mt.6300012","volume":"15","author":"T Kurai","year":"2007","unstructured":"Kurai T, Hisayasu S, Kitagawa R, Migita M, Suzuki H, Hirai Y et al. AAV1 mediated co-expression of formylglycine-generating enzyme and arylsulfatase A efficiently corrects sulfatide storage in a mouse model of metachromatic leukodystrophy. Mol Ther 2007; 15: 38\u201343.","journal-title":"Mol Ther"},{"key":"BFgt201417_CR10","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1089\/104303402760128612","volume":"13","author":"C Janson","year":"2002","unstructured":"Janson C, McPhee S, Bilaniuk L, Haselgrove J, Testaiuti M, Freese A et al. Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain. Hum Gene Ther 2002; 13: 1391\u20131412.","journal-title":"Hum Gene Ther"},{"key":"BFgt201417_CR11","doi-asserted-by":"publisher","first-page":"165ra163","DOI":"10.1126\/scitranslmed.3003454","volume":"4","author":"P Leone","year":"2012","unstructured":"Leone P, Shera D, McPhee SW, Francis JS, Kolodny EH, Bilaniuk LT et al. Long-term follow-up after gene therapy for canavan disease. Sci Transl Med 2012; 4: 165ra163.","journal-title":"Sci Transl Med"},{"key":"BFgt201417_CR12","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/mt.2010.74","volume":"18","author":"N Miyake","year":"2010","unstructured":"Miyake N, Miyake K, Karlsson S, Shimada T . Successful treatment of metachromatic leukodystrophy using bone marrow transplantation of HoxB4 overexpressing cells. Mol Ther 2010; 18: 1373\u20131378.","journal-title":"Mol Ther"},{"key":"BFgt201417_CR13","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1172\/JCI28873","volume":"116","author":"A Biffi","year":"2006","unstructured":"Biffi A, Capotondo A, Fasano S, del Carro U, Marchesini S, Azuma H et al. Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice. J Clin Invest 2006; 116: 3070\u20133082.","journal-title":"J Clin Invest"},{"key":"BFgt201417_CR14","doi-asserted-by":"publisher","first-page":"1233158","DOI":"10.1126\/science.1233158","volume":"341","author":"A Biffi","year":"2013","unstructured":"Biffi A, Montini E, Lorioli L, Cesani M, Fumagalli F, Plati T et al. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science 2013; 341: 1233158.","journal-title":"Science"},{"key":"BFgt201417_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nbt.1515","volume":"27","author":"KD Foust","year":"2009","unstructured":"Foust KD, Nurre E, Montgomery CL, Hernandez A, Chan CM, Kaspar BK . Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol 2009; 27: 59\u201365.","journal-title":"Nat Biotechnol"},{"key":"BFgt201417_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.brainres.2011.03.014","volume":"1389","author":"N Miyake","year":"2011","unstructured":"Miyake N, Miyake K, Yamamoto M, Hirai Y, Shimada T . Global gene transfer into the CNS across the BBB after neonatal systemic delivery of single-stranded AAV vectors. Brain Res 2011; 1389: 19\u201326.","journal-title":"Brain Res"},{"key":"BFgt201417_CR17","doi-asserted-by":"publisher","first-page":"9513","DOI":"10.1128\/JVI.01001-08","volume":"82","author":"K Inagaki","year":"2008","unstructured":"Inagaki K, Piao C, Kotchey NM, Wu X, Nakai H . Frequency and spectrum of genomic integration of recombinant adeno-associated virus serotype 8 vector in neonatal mouse liver. J Virol 2008; 82: 9513\u20139524.","journal-title":"J Virol"},{"key":"BFgt201417_CR18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00401-004-0883-6","volume":"108","author":"D Wittke","year":"2004","unstructured":"Wittke D, Hartmann D, Gieselmann V, Lullmann-Rauch R . Lysosomal sulfatide storage in the brain of arylsulfatase A-deficient mice: cellular alterations and topographic distribution. Acta Neuropathol 2004; 108: 261\u2013271.","journal-title":"Acta Neuropathol"},{"key":"BFgt201417_CR19","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/jgm.1496","volume":"12","author":"C Hu","year":"2010","unstructured":"Hu C, Busuttil RW, Lipshutz GS . RH10 provides superior transgene expression in mice when compared with natural AAV serotypes for neonatal gene therapy. J Gene Med 2010; 12: 766\u2013778.","journal-title":"J Gene Med"},{"key":"BFgt201417_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1385\/IR:22:2-3:177","volume":"22","author":"AM Garcia","year":"2000","unstructured":"Garcia AM, Fadel SA, Cao S, Sarzotti M . T cell immunity in neonates. Immunol Res 2000; 22: 177\u2013190.","journal-title":"Immunol Res"},{"key":"BFgt201417_CR21","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/mt.2012.167","volume":"21","author":"A Ciesielska","year":"2013","unstructured":"Ciesielska A, Hadaczek P, Mittermeyer G, Zhou S, Wright JF, Bankiewicz KS et al. Cerebral infusion of AAV9 vector-encoding non-self proteins can elicit cell-mediated immune responses. Mol Ther 2013; 21: 158\u2013166.","journal-title":"Mol Ther"},{"key":"BFgt201417_CR22","doi-asserted-by":"publisher","first-page":"e17639","DOI":"10.1371\/journal.pone.0017639","volume":"6","author":"LH Comley","year":"2011","unstructured":"Comley LH, Wishart TM, Baxter B, Murray LM, Nimmo A, Thomson D et al. Induction of cell stress in neurons from transgenic mice expressing yellow fluorescent protein: implications for neurodegeneration research. PLoS One 2011; 6: e17639.","journal-title":"PLoS One"},{"key":"BFgt201417_CR23","first-page":"911","volume":"2","author":"H Goto","year":"2003","unstructured":"Goto H, Yang B, Petersen D, Pepper KA, Alfaro PA, Kohn DB et al. Transduction of green fluorescent protein increased oxidative stress and enhanced sensitivity to cytotoxic drugs in neuroblastoma cell lines. Mol Cancer Ther 2003; 2: 911\u2013917.","journal-title":"Mol Cancer Ther"},{"key":"BFgt201417_CR24","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1006\/bbrc.1999.0954","volume":"260","author":"HS Liu","year":"1999","unstructured":"Liu HS, Jan MS, Chou CK, Chen PH, Ke NJ . Is green fluorescent protein toxic to the living cells? Biochem Biophys Res Commun 1999; 260: 712\u2013717.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFgt201417_CR25","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1006\/mthe.2002.0609","volume":"5","author":"ER Detrait","year":"2002","unstructured":"Detrait ER, Bowers WJ, Halterman MW, Giuliano RE, Bennice L, Federoff HJ et al. Reporter gene transfer induces apoptosis in primary cortical neurons. Mol Ther 2002; 5: 723\u2013730.","journal-title":"Mol Ther"},{"key":"BFgt201417_CR26","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1128\/CVI.05107-11","volume":"18","author":"R Calcedo","year":"2011","unstructured":"Calcedo R, Morizono H, Wang L, McCarter R, He J, Jones D et al. Adeno-associated virus antibody profiles in newborns, children, and adolescents. Clin Vaccine Immunol 2011; 18: 1586\u20131588.","journal-title":"Clin Vaccine Immunol"},{"key":"BFgt201417_CR27","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1182\/blood-2005-08-3229","volume":"107","author":"CD Scallan","year":"2006","unstructured":"Scallan CD, Jiang H, Liu T, Patarroyo-White S, Sommer JM, Zhou S et al. Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice. Blood 2006; 107: 1810\u20131817.","journal-title":"Blood"},{"key":"BFgt201417_CR28","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1089\/hum.2009.182","volume":"21","author":"S Boutin","year":"2010","unstructured":"Boutin S, Monteilhet V, Veron P, Leborgne C, Benveniste O, Montus MF et al. Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors. Hum Gene Ther 2010; 21: 704\u2013712.","journal-title":"Hum Gene Ther"},{"key":"BFgt201417_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","volume":"122","author":"F Mingozzi","year":"2013","unstructured":"Mingozzi F, High KA . Immune responses to AAV vectors: overcoming barriers to successful gene therapy. Blood 2013; 122: 23\u201336.","journal-title":"Blood"},{"key":"BFgt201417_CR30","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nm1358","volume":"12","author":"CS Manno","year":"2006","unstructured":"Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJ et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 2006; 12: 342\u2013347.","journal-title":"Nat Med"},{"key":"BFgt201417_CR31","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","volume":"365","author":"AC Nathwani","year":"2011","unstructured":"Nathwani AC, Tuddenham EG, Rangarajan S, Rosales C, McIntosh J, Linch DC et al. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med 2011; 365: 2357\u20132365.","journal-title":"N Engl J Med"},{"key":"BFgt201417_CR32","doi-asserted-by":"publisher","first-page":"14821","DOI":"10.1073\/pnas.93.25.14821","volume":"93","author":"B Hess","year":"1996","unstructured":"Hess B, Saftig P, Hartmann D, Coenen R, Lullmann-Rauch R, Goebel HH et al. Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy. Proc Natl Acad Sci USA 1996; 93: 14821\u201314826.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201417_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/hmg\/ddi425","volume":"15","author":"C Sevin","year":"2006","unstructured":"Sevin C, Benraiss A, Van Dam D, Bonnin D, Nagels G, Verot L et al. Intracerebral adeno-associated virus-mediated gene transfer in rapidly progressive forms of metachromatic leukodystrophy. Hum Mol Genet 2006; 15: 53\u201364.","journal-title":"Hum Mol Genet"},{"key":"BFgt201417_CR34","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S0006-8993(99)02085-5","volume":"847","author":"R D'Hooge","year":"1999","unstructured":"D'Hooge R, Coenen R, Gieselmann V, Lullmann-Rauch R, De Deyn PP . Decline in brainstem auditory-evoked potentials coincides with loss of spiral ganglion cells in arylsulfatase A-deficient mice. Brain Res 1999; 847: 352\u2013356.","journal-title":"Brain Res"},{"key":"BFgt201417_CR35","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/85454","volume":"7","author":"A Consiglio","year":"2001","unstructured":"Consiglio A, Quattrini A, Martino S, Bensadoun JC, Dolcetta D, Trojani A et al. In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice. Nat Med 2001; 7: 310\u2013316.","journal-title":"Nat Med"},{"key":"BFgt201417_CR36","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/jgm.1325","volume":"11","author":"N Iwamoto","year":"2009","unstructured":"Iwamoto N, Watanabe A, Yamamoto M, Miyake N, Kurai T, Teramoto A et al. Global diffuse distribution in the brain and efficient gene delivery to the dorsal root ganglia by intrathecal injection of adeno-associated viral vector serotype 1. J Gene Med 2009; 11: 498\u2013505.","journal-title":"J Gene Med"},{"key":"BFgt201417_CR37","doi-asserted-by":"publisher","first-page":"11854","DOI":"10.1073\/pnas.182412299","volume":"99","author":"GP Gao","year":"2002","unstructured":"Gao GP, Alvira MR, Wang L, Calcedo R, Johnston J, Wilson JM . Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA 2002; 99: 11854\u201311859.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201417_CR38","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1089\/10430349950017563","volume":"10","author":"WT Hermens","year":"1999","unstructured":"Hermens WT, ter Brake O, Dijkhuizen PA, Sonnemans MA, Grimm D, Kleinschmidt JA et al. Purification of recombinant adeno-associated virus by iodixanol gradient ultracentrifugation allows rapid and reproducible preparation of vector stocks for gene transfer in the nervous system. Hum Gene Ther 1999; 10: 1885\u20131891.","journal-title":"Hum Gene Ther"},{"key":"BFgt201417_CR39","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1272\/jnms.79.394","volume":"79","author":"K Miyake","year":"2012","unstructured":"Miyake K, Miyake N, Yamazaki Y, Shimada T, Hirai Y . Serotype-independent method of recombinant adeno-associated virus (AAV) vector production and purification. J Nippon Med Sch 2012; 79: 394\u2013402.","journal-title":"J Nippon Med Sch"},{"key":"BFgt201417_CR40","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/BF00306130","volume":"5","author":"JE Scott","year":"1965","unstructured":"Scott JE, Dorling J . Differential staining of acid glycosaminoglycans (mucopolysaccharides) by Alcian blue in salt solutions. Histochemie 1965; 5: 221\u2013233.","journal-title":"Histochemie"},{"key":"BFgt201417_CR41","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch J, Lees M, Sloane Stanley GH . A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957; 226: 497\u2013509.","journal-title":"J Biol Chem"},{"key":"BFgt201417_CR42","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","volume":"19","author":"RJ Carter","year":"1999","unstructured":"Carter RJ, Lione LA, Humby T, Mangiarini L, Mahal A, Bates GP et al. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci 1999; 19: 3248\u20133257.","journal-title":"J Neurosci"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt201417.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201417","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201417.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T17:19:22Z","timestamp":1716571162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,27]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["BFgt201417"],"URL":"https:\/\/doi.org\/10.1038\/gt.2014.17","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,27]]},"assertion":[{"value":"19 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}